Clinical Trial Detail

NCT ID NCT01624285
Title Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

hepatocellular carcinoma

Therapies

Sorafenib

Age Groups: adult

No variant requirements are available.